Skip to main content
    D

    DarioHealth Corp (DRIO)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $5.13
    -0.32 (-5.87%)

    Market Cap: $53.41M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    46%(18/39)
    Avg Surprise
    -74.96%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.51
    Range$-0.51 - $-0.51
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.59+13.6%
    60d ago$-0.63+18.4%
    30d ago$-0.63+18.4%
    7d ago$-0.63+18.4%
    Current$-0.51
    Revenue Consensus
    $5M
    Range$5M - $5M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.35
    Range$-0.36 - $-0.34
    2 analysts
    Revenue Consensus
    $6M
    Range$5M - $6M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.35---
    Sep 26EST
    		-$-0.51---
    Jun 26
    Reported Aug 11
    		$-0.85$-1.19+28.57%Beat+79.2%
    Mar 26
    Reported May 13
    		$-0.95$-0.85-11.76%Miss+60.1%
    Dec 25
    Reported Mar 19
    		$-0.77N/A+51.86%Beat-1667.7%
    Sep 25
    Reported Nov 13
    		$-2.22$-2.42+8.26%Beat+39.5%
    Jun 25
    Reported Aug 12
    		$-4.09$-2.07-97.58%Miss-0.7%
    Mar 25
    Reported May 14
    		$-2.38$-1.10-116.36%Miss-355.9%
    Dec 24
    Reported Mar 10
    		$-0.04N/A+80.90%Beat+91.3%
    Sep 24
    Reported Nov 7
    		$-3.67$-3.60-1.94%Miss+43.4%
    Jun 24
    Reported Aug 8
    		$-4.06$-5.80+30.00%Beat+51.3%
    Mar 24
    Reported May 15
    		$0.93N/A+112.57%Beat+119.0%
    Dec 23
    Reported Mar 28
    		$-0.50$-0.55+9.09%Beat+2.0%
    Sep 23
    Reported Nov 2
    		$-6.48$-6.40-1.25%Miss+21.5%
    Jun 23
    Reported Aug 10
    		$-8.34$-6.00-39.00%Miss+41.1%
    Mar 23
    Reported May 11
    		$-4.90$-7.40+33.78%Beat+71.3%
    Dec 22
    Reported Mar 9
    		$-0.51$-0.65+21.54%Beat+53.2%
    Sep 22
    Reported Nov 14
    		$-8.25$-11.40+27.63%Beat+44.9%
    Jun 22
    Reported Aug 15
    		$-14.15$-10.40-36.06%Miss+21.2%
    Mar 22
    Reported May 12
    		$-17.05$-14.70-15.99%Miss-1753.3%
    Dec 21
    Reported Mar 22
    		$-1.09$-1.06-2.83%Miss+94.9%
    Sep 21
    Reported Nov 15
    		$-14.98$-15.67+4.40%Beat-5.5%
    Jun 21
    Reported Aug 16
    		$-17.95$-13.56-32.37%Miss-32.0%
    Mar 21
    Reported May 17
    		$-0.92$-1.04+11.54%Beat+97.1%
    Dec 20
    Reported Mar 9
    		$-21.20$-18.12-17.00%Miss-174.6%
    Sep 20
    Reported Nov 12
    		$-14.20$-12.10-17.36%Miss+40.8%
    Jun 20
    Reported Aug 12
    		$-13.60N/A+55.12%Beat-423.1%
    Mar 20
    Reported May 12
    		$-31.40$-7.80-302.56%Miss+47.7%
    Dec 19
    Reported Mar 17
    		$-7.72$-1.02-656.86%Miss-250.9%
    Sep 19
    Reported Oct 28
    		$-24.00$-40.00+40.00%Beat-605.9%
    Jun 19
    Reported Aug 13
    		$-2.60$-2.70+3.70%Beat+98.0%
    Mar 19
    Reported May 13
    		$-60.00$-52.00-15.38%Miss+25.0%
    Dec 18
    Reported Mar 25
    		$-2.20$-3.00+26.67%Beat+91.3%
    Sep 18
    Reported Nov 13
    		$-3.40$-0.18-1788.89%Miss+97.2%
    Jun 18
    Reported Aug 9
    		$-128.00$-72.00-77.78%Miss+25.6%
    Mar 18
    Reported May 15
    		$-80.00$-68.00-17.65%Miss-17877.8%
    Dec 17
    Reported Mar 19
    		$-25.20$-6.00-320.00%Miss+93.4%
    Sep 17
    Reported Nov 14
    		$-120.00$-122.00+1.64%Beat-
    Jun 17
    Reported Aug 14
    		$-172.00$-120.00-43.33%Miss-
    Mar 17
    Reported May 15
    		$0.45$-0.30+250.00%Beat-
    Dec 16
    Reported Mar 22
    		$-384.00$-184.00-108.70%Miss-

    Key Metrics

    Valuation
    P/E Ratio-1.07EV/EBITDAN/A
    Price/FCF-1.88xFCF Yield-53.16%
    Profitability
    Profit Margin-169.90%Operating Margin-125.20%
    ROE-59.90%ROIC-27.67%
    Financial Health
    Debt/Equity0.56xInterest CoverageN/A
    Current Ratio2.31xQuick Ratio1.92x
    Trading Statistics
    Beta1.18Avg Volume18.69K
    52-Week High$16.5052-Week Low$5.13

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.71
    SMA 20$6.23
    SMA 50$6.79
    SMA 200$8.19
    EMA 10$5.69
    EMA 20$6.06
    EMA 50$6.57
    EMA 200$8.14

    MACD

    Line: -0.43Signal: -0.33Hist: -0.09

    ADX

    ADX: 24.3+DI: 15.3-DI: 20.9

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down100.0
    PSAR$6.00

    Bollinger Bands

    Upper Band$7.48
    Lower Band$4.98
    %B Position4012%(Upper)
    Band Width0.06

    RSI (14-Day)

    Neutral
    33.2

    Momentum Oscillators

    Stoch %K14.8
    Stoch %D15.6
    Williams %R-94.4
    ROC (10d)-16.7%
    Momentum-1.03
    CCI (20d)-136.3
    MFI (14d)34.0

    Volatility Measures

    ATR (14d)$0.49(9.6%)
    StdDev (20d)0.62
    Hist Vol75.3%(High)

    Volume Flow

    VWAP$5.21
    OBV280.1K
    AD Line10.2B
    CMF (20d)-0.204

    Volume Metrics

    Avg Vol (20d)19.1K
    Vol Ratio0.5x
    VWMA (20d)$6.35

    Pivot Points

    R3$6.48
    R2$6.14
    R1$5.80
    Pivot Point$5.46
    S1$5.12
    S2$4.78
    S3$4.44

    Advanced Oscillators

    TSI-25.27
    Ultimate Osc35.5
    KST-169.95

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$5.18M$5.58M$5.23M$5.01M$5.37M$6.75M$7.60M$7.42M$6.25M$5.76M$3.62M$3.52M
    Cost of Revenue$1.99M$2.38M$2.43M$1.99M$2.40M$2.87M$3.40M$3.55M$3.50M$3.33M$3.48M$2.91M
    Gross Profit$3.19M$3.20M$2.80M$3.02M$2.96M$3.88M$4.20M$3.88M$2.76M$2.43M$132,000$610,000
    Operating Expenses$9.67M$10.51M$11.37M$12.50M$12.16M$13.29M$15.87M$15.91M$18.95M$20.29M$14.35M$16.16M
    R&D$2.10M$2.38M$2.63M$3.33M$3.72M$4.11M$5.28M$5.45M$6.81M$6.64M$4.20M$5.67M
    SG&A$2.60M$3.23M$4.10M$4.57M$3.21M$3.31M$5.01M$3.73M$5.00M$6.74M$5.53M$4.13M
    Operating Income$-6,479,000$-7,309,000$-8,562,000$-9,484,000$-9,200,000$-9,409,000$-11,668,000$-12,030,000$-16,191,000$-17,855,000$-14,215,000$-15,546,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$1.12M$0$386,000$1.16M$0$0$0$0$0$0$6,000$186,000
    Income Before Tax$-7,596,000$-7,309,000$-8,948,000$-10,466,000$-12,990,000$-9,205,000$-9,477,000$-12,343,000$-13,610,000$-9,169,000$-14,221,000$-15,732,000
    Income Tax Expense$328,000$0$83,000$0$0$22,000$155,000$-13,000$0$-1,994,000$64,000$0
    Net Income$-7,924,000$-8,249,000$-9,031,000$-10,466,000$-12,990,000$-9,227,000$-9,632,000$-12,330,000$-13,610,000$-7,175,000$-14,285,000$-15,732,000
    EBITDA$-5,958,000$-6,785,000$-6,551,000$-8,763,000$-12,188,000$-7,949,000$-7,342,000$-10,215,000$-11,772,000$-7,843,000$-12,970,000$-14,730,000
    EBIT$-6,473,000$-7,309,000$-7,085,000$-9,309,000$-12,990,000$-9,205,000$-9,477,000$-12,343,000$-13,610,000$-9,169,000$-14,221,000$-15,732,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DRIO

    News

    DarioHealth stock gained 3.79 percent as Aon backs savings

    DarioHealth (DRIO) stock rose 3.79% after Aon's review confirmed potential annual healthcare cost savings of 2.5% to 7.2% for its digital health platform. Despite these positive findings strengthening its value...

    AD HOC NEWS•10/7/26•Somewhat-Bullish

    DarioHealth stock fell 10.22 percent on October 5

    DarioHealth's stock (DRIO) dropped 10.22% on October 5, closing at USD 5.80 on Nasdaq, which also marked its 52-week low. Despite a Q2 2026 revenue decline to USD 5.2 million...

    AD HOC NEWS•10/6/26•Somewhat-Bearish

    DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs

    DarioHealth announced an independent analysis by Aon, a global professional services firm, which supports an estimated 2.5% to 7.2% reduction in total healthcare costs for covered populations using Dario's AI-powered...

    Morningstar•10/6/26•Neutral

    DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs

    DarioHealth announced the results of an independent review by Aon, which supports an estimated 2.5% to 7.2% in-year reduction in total healthcare costs for populations using Dario's digital health platform. This...

    PR Newswire•10/6/26•Bullish

    DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs

    DarioHealth announced an independent analysis by Aon, a global professional services firm, indicating that Dario's digital health platform can lead to a 2.5% to 7.2% in-year reduction in total healthcare costs....

    Yahoo Finance•10/6/26•Bullish

    DRIO Valuation and Fair Value

    P/E
    -1.1x
    Forward P/E
    10.6x
    P/FCF
    -1.9x
    PEG
    0.0x
    P/B
    0.9x
    See GNG's fair value

    DRIO Profitability: Margins, ROIC and FCF

    Gross margin
    58.2%
    Operating margin
    -125.2%
    Net margin
    -169.9%
    ROIC
    -27.7%
    ROE
    -59.9%
    FCF margin
    -121.3%
    FCF yield
    -53.2%

    DRIO Competitors

    CompanyTicker
    Kezar Life Sciences IncKZR
    Kalaris Therapeutics, Inc.KLRS
    Fractyl Health, Inc. Common StockGUTS
    Inspira Technologies Oxy BHN LtdIINN
    Gossamer Bio IncGOSS
    Mink Therapeutics IncINKT
    Pliant Therapeutics IncPLRX
    Alterity Therapeutics LtdATHE

    Sector: Healthcare

    DRIO Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    0
    Buy
    4
    Hold
    1
    Sell
    0
    Strong Sell
    0

    DRIO Bull Case vs Bear Case

    Bull case

    • 80.0% of DRIO's analyst ratings are Buy or Strong Buy.

    Bear case

    • DRIO has a -169.9% net profit margin.
    • DRIO's quarterly revenue changed -3.6% year over year.

    DRIO Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -7.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.51
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About DRIO

    Does DRIO pay dividends?

    DarioHealth Corp (DRIO) does not currently pay a regular dividend.

    What is DRIO's market cap?

    DarioHealth Corp (DRIO) has a market capitalization of $53.41M with a current stock price of $5.13.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In